The Recent Advances on Liver Cancer Stem Cells: Biomarkers, Separation, and Therapy
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Recent Advances on Liver Cancer Stem Cells: Biomarkers, Separation, and Therapy
Authors
Keywords
-
Journal
Analytical Cellular Pathology
Volume 2017, Issue -, Pages 1-9
Publisher
Hindawi Limited
Online
2017-07-28
DOI
10.1155/2017/5108653
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Positive Correlation of Oct4 and ABCG2 to Chemotherapeutic Resistance in CD90+CD133+ Liver Cancer Stem Cells
- (2018) Qian Jia et al. Cellular Reprogramming
- Poly lactic-co-glycolic acid controlled delivery of disulfiram to target liver cancer stem-like cells
- (2017) Zhipeng Wang et al. Nanomedicine-Nanotechnology Biology and Medicine
- CD133+ liver cancer stem cells resist interferon-gamma-induced autophagy
- (2016) Jian Li et al. BMC CANCER
- A CD13 inhibitor, ubenimex, synergistically enhances the effects of anticancer drugs in hepatocellular carcinoma
- (2016) MASAFUMI YAMASHITA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Keratin 19, a Cancer Stem Cell Marker in Human Hepatocellular Carcinoma
- (2015) T. Kawai et al. CLINICAL CANCER RESEARCH
- Activation of the transforming growth factor-β/SMAD transcriptional pathway underlies a novel tumor-promoting role of sulfatase 1 in hepatocellular carcinoma
- (2015) Renumathy Dhanasekaran et al. HEPATOLOGY
- 1118-20, an indazole diarylurea compound, inhibits hepatocellular carcinoma HepG2 proliferation and tumour angiogenesis involving Wnt/β-catenin pathway and receptor tyrosine kinases
- (2015) Yu-Yin Lu et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- iRGD-conjugated DSPE-PEG2000 nanomicelles for targeted delivery of salinomycin for treatment of both liver cancer cells and cancer stem cells
- (2015) Xiaoli Mao et al. Nanomedicine
- Ultrasound-targeted microbubble destruction-mediated downregulation of CD133 inhibits epithelial-mesenchymal transition, stemness and migratory ability of liver cancer stem cells
- (2015) YAN-MIN LIU et al. ONCOLOGY REPORTS
- Serum DLK1 is a potential prognostic biomarker in patients with hepatocellular carcinoma
- (2015) Hong Li et al. TUMOR BIOLOGY
- TQ inhibits hepatocellular carcinoma growth in vitro and in vivo via repression of Notch signaling
- (2015) Xiquan Ke et al. Oncotarget
- Graphene oxide selectively targets cancer stem cells, across multiple tumor types: Implications for non-toxic cancer treatment, via “differentiation-based nano-therapy”
- (2015) Marco Fiorillo et al. Oncotarget
- SALL4: Engine of Cell Stemness
- (2014) Jianhua Xiong CURRENT GENE THERAPY
- Epigenetic reprogramming modulates malignant properties of human liver cancer
- (2014) Chiara Raggi et al. HEPATOLOGY
- Destruxin B inhibits hepatocellular carcinoma cell growth through modulation of the Wnt/β-catenin signaling pathway and epithelial–mesenchymal transition
- (2014) Thanh-Tuan Huynh et al. TOXICOLOGY IN VITRO
- Serum SALL4 Is a Novel Prognosis Biomarker with Tumor Recurrence and Poor Survival of Patients in Hepatocellular Carcinoma
- (2014) Su-xia Han et al. Journal of Immunology Research
- EpCAM-Targeted Therapy for Human Hepatocellular Carcinoma
- (2013) Kousuke Ogawa et al. ANNALS OF SURGICAL ONCOLOGY
- 1B50-1, a mAb Raised against Recurrent Tumor Cells, Targets Liver Tumor-Initiating Cells by Binding to the Calcium Channel α2δ1 Subunit
- (2013) Wei Zhao et al. CANCER CELL
- Twist2 promotes self-renewal of liver cancer stem-like cells by regulating CD24
- (2013) Allan Yi Liu et al. CARCINOGENESIS
- CD44 integrates signaling in normal stem cell, cancer stem cell and (pre)metastatic niches
- (2013) Karin Williams et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Expression of Intercellular Adhesion Molecule 1 by Hepatocellular Carcinoma Stem Cells and Circulating Tumor Cells
- (2013) Shupeng Liu et al. GASTROENTEROLOGY
- Stem cell geneSALL4in aggressive hepatocellular carcinoma: A cancer stem cell-specific target?
- (2013) Elizabeth Yakaboski et al. HEPATOLOGY
- The transcription factor SALL4 regulates stemness of EpCAM-positive hepatocellular carcinoma
- (2013) Sha Sha Zeng et al. JOURNAL OF HEPATOLOGY
- Self-renewal as a therapeutic target in human colorectal cancer
- (2013) Antonija Kreso et al. NATURE MEDICINE
- SALL4—a cancer marker and target
- (2013) Bryony Jones Nature Reviews Clinical Oncology
- Oncofetal Gene SALL4 in Aggressive Hepatocellular Carcinoma
- (2013) Kol Jia Yong et al. NEW ENGLAND JOURNAL OF MEDICINE
- Expression of Potential Cancer Stem Cell Marker ABCG2 is Associated with Malignant Behaviors of Hepatocellular Carcinoma
- (2013) Guang Zhang et al. Gastroenterology Research and Practice
- Clinical Significance of Axin and β-catenin Protein Expression in Primary Hepatocellular Carcinomas
- (2012) Cheng-Nong Guan et al. Asian Pacific Journal of Cancer Prevention
- Notch Signaling Is Activated in Human Hepatocellular Carcinoma and Induces Tumor Formation in Mice
- (2012) Augusto Villanueva et al. GASTROENTEROLOGY
- Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma
- (2012) Juanjuan Shan et al. HEPATOLOGY
- Discrete nature of EpCAM+and CD90+cancer stem cells in human hepatocellular carcinoma
- (2012) Taro Yamashita et al. HEPATOLOGY
- OV6+ tumor-initiating cells contribute to tumor progression and invasion in human hepatocellular carcinoma
- (2012) Wen Yang et al. JOURNAL OF HEPATOLOGY
- Hepatocellular carcinoma
- (2012) Alejandro Forner et al. LANCET
- Expression of K19 and K7 in dysplastic nodules and hepatocellular carcinoma
- (2012) JUN SANG BAE et al. Oncology Letters
- Increased CD13 Expression Reduces Reactive Oxygen Species, Promoting Survival of Liver Cancer Stem Cells via an Epithelial–Mesenchymal Transition-like Phenomenon
- (2011) Ho Min Kim et al. ANNALS OF SURGICAL ONCOLOGY
- CD133+ liver cancer stem cells modulate radioresistance in human hepatocellular carcinoma
- (2011) Lian Shu Piao et al. CANCER LETTERS
- CD24+ Liver Tumor-Initiating Cells Drive Self-Renewal and Tumor Initiation through STAT3-Mediated NANOG Regulation
- (2011) Terence Kin Wah Lee et al. Cell Stem Cell
- Eyes Wide Open: A Critical Review of Sphere-Formation as an Assay for Stem Cells
- (2011) Erika Pastrana et al. Cell Stem Cell
- Human hepatocellular carcinomas with “Stemness”-related marker expression: keratin 19 expression and a poor prognosis
- (2011) Haeryoung Kim et al. HEPATOLOGY
- CD133+ liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signaling
- (2011) Kwan Ho Tang et al. HEPATOLOGY
- Aldehyde dehydrogenase 1 expression predicts poor prognosis in triple-negative breast cancer
- (2011) Yasuyo Ohi et al. HISTOPATHOLOGY
- Hedgehog Signaling Antagonist Promotes Regression of Both Liver Fibrosis and Hepatocellular Carcinoma in a Murine Model of Primary Liver Cancer
- (2011) George M. Philips et al. PLoS One
- CD13 is a therapeutic target in human liver cancer stem cells
- (2010) Naotsugu Haraguchi et al. JOURNAL OF CLINICAL INVESTIGATION
- Antibodies targeting cancer stem cells: A new paradigm in immunotherapy?
- (2010) Mahendra P. Deonarain et al. mAbs
- EZH2 Is Essential for Glioblastoma Cancer Stem Cell Maintenance
- (2009) M.-L. Suva et al. CANCER RESEARCH
- Cancer stem/progenitor cells are highly enriched in CD133+CD44+population in hepatocellular carcinoma
- (2009) Zheng Zhu et al. INTERNATIONAL JOURNAL OF CANCER
- EpCAM, a new marker for cancer stem cells in hepatocellular carcinoma
- (2009) Benoit Terris et al. JOURNAL OF HEPATOLOGY
- Significance of CD90+ Cancer Stem Cells in Human Liver Cancer
- (2008) Zhen Fan Yang et al. CANCER CELL
- Wnt/ -Catenin Signaling Contributes to Activation of Normal and Tumorigenic Liver Progenitor Cells
- (2008) W. Yang et al. CANCER RESEARCH
- EpCAM-Positive Hepatocellular Carcinoma Cells Are Tumor-Initiating Cells With Stem/Progenitor Cell Features
- (2008) Taro Yamashita et al. GASTROENTEROLOGY
- Identification of local and circulating cancer stem cells in human liver cancer
- (2008) Zhen Fan Yang et al. HEPATOLOGY
- CD133+ liver cancer stem cells from methionine adenosyl transferase 1A-deficient mice demonstrate resistance to transforming growth factor (TGF)-β-induced apoptosis
- (2008) Wei Ding et al. HEPATOLOGY
- Differentiation therapy of hepatocellular carcinoma in mice with recombinant adenovirus carrying hepatocyte nuclear factor-4α gene
- (2008) Chuan Yin et al. HEPATOLOGY
- Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma
- (2008) W. Song et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Aldehyde Dehydrogenase Discriminates the CD133 Liver Cancer Stem Cell Populations
- (2008) S. Ma et al. MOLECULAR CANCER RESEARCH
- Expansion of CD133-Expressing Liver Cancer Stem Cells in Liver-Specific Phosphatase and Tensin Homolog Deleted on Chromosome 10-Deleted Mice
- (2008) C. Bart Rountree et al. STEM CELLS
- Deregulated expression of Notch receptors in human hepatocellular carcinoma
- (2007) J. Gao et al. DIGESTIVE AND LIVER DISEASE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started